22nd week of 2022 patent applcation highlights part 9 |
Patent application number | Title | Published |
20220168347 | T CELL RECEPTORS AND METHODS OF USE THEREOF | 2022-06-02 |
20220168348 | METHOD FOR CULTURING ALLOGENEIC IMMUNE CELL, IMMUNE CELL CULTURE OBTAINED THEREBY, AND IMMUNE CELL THERAPEUTIC AGENT COMPRISING SAME | 2022-06-02 |
20220168349 | RECOMBINANT erIL-15 NK CELLS | 2022-06-02 |
20220168350 | Lung Cancer Specific Marrow Infiltrating Lymphocytes and Uses Thereof | 2022-06-02 |
20220168351 | TREATMENT OF A CANINE CD20 POSITIVE DISEASE OR CONDITION USING A CANINE CD20-SPECIFIC CHIMERIC ANTIGEN RECEPTOR | 2022-06-02 |
20220168352 | CAR T-CELL ADJUVANT THERAPIES | 2022-06-02 |
20220168353 | FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY | 2022-06-02 |
20220168354 | Compositions Comprising Milk Fat Globules | 2022-06-02 |
20220168355 | Methods for Treating Conditions by Restoring Central Nervous System Endocrine Gland Function, and Compositions and Devices for Practicing the Same | 2022-06-02 |
20220168356 | ALLOGRAFTS CONTAINING VIABLE CELLS AND METHODS THEROF | 2022-06-02 |
20220168357 | METHOD FOR PRODUCING BIOLOGICAL TISSUE-LIKE STRUCTURE | 2022-06-02 |
20220168358 | MITOCHONDRIAL TRANSPLANTATION AND USE THEREOF IN OCULAR DISEASES | 2022-06-02 |
20220168359 | METHODS AND COMPOSITIONS FOR PRODUCING HEPATOCYTE-LIKE CELLS | 2022-06-02 |
20220168360 | COMPOSITIONS, DEVICES, AND METHODS FOR TREATING RESPIRATORY DISORDERS | 2022-06-02 |
20220168361 | METHODS FOR MEASURING THERAPEUTIC EFFECTS OF RETINAL DISEASE THERAPIES | 2022-06-02 |
20220168362 | BACTERIA ENGINEERED TO TREAT DISORDERS INVOLVING THE CATABOLISM OF A BRANCHED CHAIN AMINO ACID | 2022-06-02 |
20220168363 | COMPOSITIONS CONTAINING BACILLAENE PRODUCING BACTERIA OR PREPARATIONS THEREOF | 2022-06-02 |
20220168364 | MODIFIED MICROORGANISMS EXPRESSING SAGA AND RELATED COMPOSITIONS FOR IMMUNOMODULATION AGAINST INFECTION AND CANCER IMMUNOTHERAPY | 2022-06-02 |
20220168365 | LACTIC ACID BACTERIA, METHODS AND USES THEREOF | 2022-06-02 |
20220168366 | NUTRACEUTICAL COMPOSITIONS | 2022-06-02 |
20220168367 | Destroying Cancer Cells While Maintaining Healthy Cell Integrity | 2022-06-02 |
20220168368 | RECOMBINANT ONCOLYTIC VIRUS, PREPARATION METHOD THEREFOR, USE THEREOF AND MEDICINE THEREOF | 2022-06-02 |
20220168369 | NUTRITIONAL COMPOSITION | 2022-06-02 |
20220168370 | ELASTASE ACTIVITY INHIBITOR, ELASTASE ACTIVITY INHIBITING TOPICAL AGENT, AND ELASTASE ACTIVITY INHIBITING FOOD AND BEVERAGE COMPOSITION | 2022-06-02 |
20220168371 | A Product and Process For A Room-Temperature Stable, Food-Grade, All-Natural, Vegan, And Phyto-Cannabinoid/Terpene/Flavonoid Colloidal Dispersion | 2022-06-02 |
20220168372 | FASTING-MIMICKING DIET PROMOTES CANCER-FREE SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA MODELS | 2022-06-02 |
20220168373 | CONTROLLED CANNABIS DECARBOXYLATION FOR AN INFUSED SOLUBLE FAT PRODUCT | 2022-06-02 |
20220168374 | FOOD SUPPLEMENT COMPOSITION WITH FUNCTIONAL ACTIVES IN THE FORM OF A LIPSTICK | 2022-06-02 |
20220168375 | TEA COMPOSITION HAVING EFFICACY FOR PREVENTING OR IMPROVING RESPIRATORY DISEASES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 2022-06-02 |
20220168376 | METHODS FOR ENHACEMENT OF DEHYDROEPIANDROSTERONE USING GREEN COFFEE BEAN EXTRACT | 2022-06-02 |
20220168377 | PEPTIDE COMPOSITION FROM EARLY HARVESTED RICE AND METHODS FOR SLIMMING OR PROMOTING GROWTH OF PROBIOTICS USING THE SAME | 2022-06-02 |
20220168378 | BIOAVAILABLE TURMERIC COMPOSITION AND PROCESS FOR PREPARATION THEREOF | 2022-06-02 |
20220168379 | LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES | 2022-06-02 |
20220168380 | FORMULATIONS FOR TREATING CRAMPS AND SPASMS | 2022-06-02 |
20220168381 | FORMULATIONS CONTAINING A SOMATOSTATIN RECEPTOR AGONIST | 2022-06-02 |
20220168382 | Pharmaceutical composition and method for relieving/eliminating morphine-induced analgesic tolerance | 2022-06-02 |
20220168383 | NEUROTENSINERGIC AGONISTS AND METHODS OF USING SAME PREVENTING OR TREATING PAIN | 2022-06-02 |
20220168384 | Anti-Bacterial Combination Therapy | 2022-06-02 |
20220168385 | USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS | 2022-06-02 |
20220168386 | NOVEL PSMA SPECIFIC BINDING PROTEINS FOR CANCER DIAGNOSIS AND TREATMENT | 2022-06-02 |
20220168387 | INHALED ADMINISTRATION OF LIPOCALIN MUTEINS | 2022-06-02 |
20220168388 | METHODS AND COMPOSITIONS FOR TUSC2 IMMUNOTHERAPY | 2022-06-02 |
20220168389 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | 2022-06-02 |
20220168390 | METHOD TO INHIBIT NEUTROPHIL RECRUITMENT TO DAMAGED TISSUE USING MYELOID-DERIVED GROWTH FACTOR | 2022-06-02 |
20220168391 | USE OF EPIDERMAL GROWTH FACTOR IN DIABETIC FOOT ULCER TREATMENT | 2022-06-02 |
20220168392 | Methods of Enhancing Protection Against Organ and Vascular Injury, Hematopoietic Recovery and Survival in Response to Total Body Radiation/Chemical Exposure | 2022-06-02 |
20220168393 | IL-12 COMPOSITIONS AND METHODS OF USE IN HEMATOPOIETIC RECOVERY | 2022-06-02 |
20220168394 | METHODS OF INDUCING OR RESTORING IMMUNE TOLERANCE | 2022-06-02 |
20220168395 | COMBINED PHARMACEUTICAL COMPOSITION | 2022-06-02 |
20220168396 | MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF | 2022-06-02 |
20220168397 | TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF | 2022-06-02 |
20220168398 | Hemostatic agent and container containing the same | 2022-06-02 |
20220168399 | FORMULATIONS FOR NUTRITIONAL SUPPORT IN SUBJECTS IN NEED THEREOF | 2022-06-02 |
20220168400 | USE OF A MANGANESE SUPEROXIDE DISMUTASE WITH HIGH STABILITY IN THE PREVENTION OR TREATMENT OF CEREBRAL STROKE | 2022-06-02 |
20220168401 | SUPER-OXIDE DISMUTASE SOLUBLE FIBER COMPOSITIONS | 2022-06-02 |
20220168402 | PIP4Ks SUPPRESS INSULIN SIGNALING AND ENHANCE IMMUNE FUNCTION THROUGH A CATALYTIC-INDEPENDENT MECHANISM | 2022-06-02 |
20220168403 | SUBCUTANEOUS TELOMERASE INHIBITOR COMPOSITIONS AND METHODS FOR USING SAME | 2022-06-02 |
20220168404 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS INFECTION, INCLUDING SARS-COV-2 | 2022-06-02 |
20220168405 | TREATMENT OF PRURITUS IN HORSES | 2022-06-02 |
20220168406 | CANCER VACCINES AGAINST MUCOSAL ANTIGENS AND METHODS OF MAKING AND USING THE SAME | 2022-06-02 |
20220168407 | USE OF TUMOR-INDEPENDENT ANTIGENS IN IMMUNOTHERAPIES | 2022-06-02 |
20220168408 | MULTI-VALENT IMMUNOTHERAPY COMPOSITION AND METHODS OF USE FOR TREATING WT1-POSITIVE CANCERS | 2022-06-02 |
20220168409 | VACCINES | 2022-06-02 |
20220168410 | ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF | 2022-06-02 |
20220168411 | PSORALEN-INACTIVATED CORONAVIRUS VACCINE AND METHOD OF PREPARATION | 2022-06-02 |
20220168412 | Chimeric Zika-Japanese Encephalitis Virus | 2022-06-02 |
20220168413 | ADJUVANTED MULTIVALENT INFLUENZA VACCINES | 2022-06-02 |
20220168414 | MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS | 2022-06-02 |
20220168415 | EXTRACELLULAR VESICLES FOR VACCINE DELIVERY | 2022-06-02 |
20220168416 | Afucosylated Anti-FGFR2IIIB Antibodies | 2022-06-02 |
20220168417 | COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR | 2022-06-02 |
20220168418 | PREVENTION OR MITIGATION OF T-CELL ENGAGING AGENT-RELATED ADVERSE EFFECTS | 2022-06-02 |
20220168419 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS | 2022-06-02 |
20220168420 | NOVEL ANTI-LAM AND ANTI-PIM6/LAM MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS | 2022-06-02 |
20220168421 | PHOTOTHERMAL THERAPY PROMOTES TUMOR INFILTRATION AND ANTITUMOR ACTIVITY OF CART T CELLS | 2022-06-02 |
20220168422 | COMPOSITIONS AND METHODS FOR MONITORING, DIAGNOSIS, PROGNOSIS, DETECTION, AND TREATMENT OF CANCER | 2022-06-02 |
20220168423 | NANOPARTICLES OF INDIRUBIN, DERIVATIVES THEREOF AND METHODS OF MAKING AND USING SAME | 2022-06-02 |
20220168424 | THERMALLY STABLE ANTIBACTERIAL QUATERNARY AMMONIUM NANOPARTICLES | 2022-06-02 |
20220168425 | COMPOSITIONS FOR RETARDING THE DECOMPOSITION OF MELATONIN IN SOLUTION | 2022-06-02 |
20220168426 | BIOORTHOGONAL COMPOSITIONS | 2022-06-02 |
20220168427 | METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION | 2022-06-02 |
20220168428 | CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS | 2022-06-02 |
20220168429 | NUCLEIC ACID MAZZOCCHIO AND METHODS OF MAKING AND USE THEREOF | 2022-06-02 |
20220168430 | THERAPEUTIC METHODS FOR TREATING HEPATITIS B | 2022-06-02 |
20220168431 | METHODS OF TREATING CANCER USING TRIMETAZIDINE-BASED COMPOUNDS | 2022-06-02 |
20220168432 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES | 2022-06-02 |
20220168433 | PROGRAMMABLE POLYMERIC DRUGS | 2022-06-02 |
20220168434 | APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP | 2022-06-02 |
20220168435 | PROGRAMMABLE POLYMERIC DRUGS | 2022-06-02 |
20220168436 | ANTIBODY DRUG CONJUGATES | 2022-06-02 |
20220168437 | ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2 | 2022-06-02 |
20220168438 | COMBINATION OF ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE AND PARP INHIBITOR | 2022-06-02 |
20220168439 | METHODS AND COMPOSITIONS FOR REDUCING METASTASES | 2022-06-02 |
20220168440 | ANTIBODY-PYRROLOBENZODIAZEPINE DEPRIVATIVE CONJUGATE | 2022-06-02 |
20220168441 | Polynucleotide-Linked Bioconjugates and Methods of Making and Using | 2022-06-02 |
20220168442 | ARTIFICIAL T-CELL STIMULATING MATRIX FOR IMMUNOTHERAPY | 2022-06-02 |
20220168443 | Engineered nono-lyposomes for a targeted therapy of atherosclerosis and preparation process thereof | 2022-06-02 |
20220168444 | INFLAMMASOME-TARGETED RNA INTERFERENCE APPROACH TO TREATING KIDNEY INJURY AND DISEASE | 2022-06-02 |
20220168445 | FOCUSED ULTRASOUND FOR NON-INVASIVE FOCAL GENE DELIVERY TO THE MAMMALIAN BRAIN | 2022-06-02 |
20220168446 | PLAKOPHILIN-2 (PKP2) GENE THERAPY USING AAV VECTOR | 2022-06-02 |